查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585604

生物相容性材料市場：依材料類型、最終用途分類 - 2025-2030 年全球預測

Biocompatible Materials Market by Material Type (Biocompatible Ceramic, Biocompatible Metals, Natural Polymers), End-use (Academic & Research Institutes, Pharmaceutical) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物相容性材料市場價值為126.3億美元，預計2024年將達到135.1億美元，複合年成長率為7.32%，到2030年將達到207.2億美元。

生物相容性材料是指與活體組織相容且引入體內時不會引起不良反應的物質。對此類材料的需求尤其來自於醫療設備、植入、藥物傳遞系統、組織工程等領域的應用，其中必須將對活生物體的不良反應降至最低。其最終用途主要涵蓋醫療保健領域，包括整形外科植入、牙科設備、心血管支架、創傷治療敷料和隱形眼鏡。生物材料市場主要受到人口老化加劇、慢性病盛行率上升以及醫療技術進步推動對創新和有效醫療保健解決方案需求的影響。開發具有更高生物相容性和功能的新型材料存在機會，例如促進組織整合和再生的生物活性陶瓷和聚合物。根據環境永續實踐使用生物分解性材料也具有潛力。然而，挑戰仍然存在，例如嚴格的監管要求和高昂的研發成本，這可能會抑制創新並限制新參與企業進入市場。其他限制包括複雜的供應鏈和原料品質的變化。對於尋求競爭優勢的主要企業來說，投資連接材料科學和生物技術的多方面研究可以帶來突破性創新。與學術機構的合作還可以促進尖端生物相容性解決方案的發展。此外，資料主導的市場分析可以為公司提供對新興趨勢和消費者需求的洞察，特別是在個人化醫療和先進傷口護理領域。在技​​術進步和不斷變化的醫療保健需求的推動下，市場的本質是高度動態的，需要持續創新和堅實的策略方法來應對挑戰並有效利用成長機會。

主要市場統計
基準年[2023] 126.3億美元
預測年份 [2024] 135.1億美元
預測年份 [2030] 207.2億美元
複合年成長率（%） 7.32%

市場動態：快速發展的生物相容性材料市場的關鍵市場洞察

供需的動態交互作用正在改變生物材料市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 先進 3D 生物材料在醫療應用的採用增加。
    • 藥物輸送系統、美容植入和傷口敷料對生物相容性材料的需求不斷成長。
  • 市場限制因素
    • 開發生物相容性材料的高成本
  • 市場機會
    • 越來越關注個人化藥物、客製化醫療設備和植入
    • 對再生醫學提供支架、組織工程載體和細胞療法的需求不斷增加
  • 市場挑戰
    • 生物相容性材料核准的嚴格法規和標準

波特五力：駕馭生物相容性材料市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物相容性材料市場的外部影響

外部宏觀環境因素在塑造生物相容材料市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解生物相容材料市場的競爭狀況

對生物相容性材料市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣生物相容性材料市場供應商的績效評估

FPNV定位矩陣是評估生物相容材料市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪生物相容性材料市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，生物相容性材料市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 先進 3D 生物材料在醫療應用的採用增加。
      • 藥物輸送系統、美容植入和傷口敷料對生物相容性材料的需求增加
    • 抑制因素
      • 開發生物相容性材料的高成本
    • 機會
      • 更加關注個人化藥物、客製化醫療設備和植入
      • 再生醫學需求不斷增加：提供支架、組織工程載體和細胞治療方法
    • 任務
      • 生物相容性材料核准的嚴格法規和標準
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依材料類型分類的生物相容性材料市場

  • 生物相容性陶瓷
  • 生物相容性金屬
  • 天然聚合物
  • 合成聚合物

第7章生物相容性材料市場：依最終用途

  • 學術研究所
  • 製藥

第8章北美和南美生物相容性材料市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區生物相容材料市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲生物相容材料市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3 H Technology Institute, LLC
  • 3D Systems Corporation
  • Ashland Inc.
  • BASF SE
  • Baxter International, Inc.
  • Celanese Corporation
  • Covestro AG
  • DuPont de Nemours, Inc.
  • Elix Polymers SLU
  • Ensinger GmbH
  • EOS GmbH
  • Evonik Industries AG
  • Formlabs Inc.
  • Foster Corporation.
  • Henkel AG & Co. KGaA,
  • Koninklijke DSM NV
  • Kurt J. Lesker Company GmbH
  • Merck KGaA
  • Mitsubishi Chemical Corporation
  • Renishaw PLC
  • Sandvik AB
  • Shin-Etsu Chemical Co., Ltd.
  • Stratasys Ltd.
  • Stryker Corporation
  • Wacker Chemie AG
Product Code: MRR-521BAA36EA0C

The Biocompatible Materials Market was valued at USD 12.63 billion in 2023, expected to reach USD 13.51 billion in 2024, and is projected to grow at a CAGR of 7.32%, to USD 20.72 billion by 2030.

Biocompatible materials refer to substances that are compatible with living tissue and do not elicit any undesirable reactions when introduced into the body. The necessity for these materials stems from their application in medical devices, implants, drug delivery systems, and tissue engineering, among others, where adverse biological responses must be minimized. Their end-use scope primarily spans healthcare sectors, including orthopedic implants, dental devices, cardiovascular stents, wound healing dressings, and contact lenses. The market for biocompatible materials is primarily influenced by the increasing aging population, the rising prevalence of chronic diseases, and advancements in medical technology that push the demand for innovative and effective healthcare solutions. Opportunities lie in developing novel materials with enhanced biocompatibility and functionality, such as bioactive ceramics and polymers that favor tissue integration and regeneration. There's also potential in leveraging biodegradable materials to align with environmentally sustainable practices. However, challenges persist, notably stringent regulatory requirements and high R&D costs, which can stifle innovation and limit market entry for new entrants. Other constraints include a complex supply chain and variability in raw material quality. For companies aiming to gain a competitive edge, investing in multifaceted research that bridges material science and biotechnology could lead to breakthrough innovations. Partnerships with academic institutions may also facilitate the development of cutting-edge biocompatible solutions. Additionally, leveraging data-driven market analytics can provide companies with insights into emerging trends and consumer needs, particularly in personalized medicine and advanced wound care sectors. The nature of the market is highly dynamic, driven by technological advancements and evolving healthcare demands, necessitating continuous innovation and a robust strategic approach to navigate challenges and capitalize on growth opportunities effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 12.63 billion
Estimated Year [2024] USD 13.51 billion
Forecast Year [2030] USD 20.72 billion
CAGR (%) 7.32%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biocompatible Materials Market

The Biocompatible Materials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in adoption of advanced 3D biocompatible materials for medical applications.
    • Growing demand for biocompatible materials for drug delivery systems, cosmetic implants, and wound dressing
  • Market Restraints
    • High cost associated with the development of biocompatible materials
  • Market Opportunities
    • Growing focus on personalized medicines and customized medical devices and implants
    • Increasing demand for regenerative medicines for providing scaffolds, carriers for tissue engineering, and cell-based therapies
  • Market Challenges
    • Stringent regulations and standards for approval of biocompatible materials

Porter's Five Forces: A Strategic Tool for Navigating the Biocompatible Materials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biocompatible Materials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biocompatible Materials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biocompatible Materials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biocompatible Materials Market

A detailed market share analysis in the Biocompatible Materials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biocompatible Materials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biocompatible Materials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biocompatible Materials Market

A strategic analysis of the Biocompatible Materials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biocompatible Materials Market, highlighting leading vendors and their innovative profiles. These include 3 H Technology Institute, LLC, 3D Systems Corporation, Ashland Inc., BASF SE, Baxter International, Inc., Celanese Corporation, Covestro AG, DuPont de Nemours, Inc., Elix Polymers SLU, Ensinger GmbH, EOS GmbH, Evonik Industries AG, Formlabs Inc., Foster Corporation., Henkel AG & Co. KGaA,, Koninklijke DSM N.V., Kurt J. Lesker Company GmbH, Merck KGaA, Mitsubishi Chemical Corporation, Renishaw PLC, Sandvik AB, Shin-Etsu Chemical Co., Ltd., Stratasys Ltd., Stryker Corporation, and Wacker Chemie AG.

Market Segmentation & Coverage

This research report categorizes the Biocompatible Materials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Material Type, market is studied across Biocompatible Ceramic, Biocompatible Metals, Natural Polymers, and Synthetic Polymers.
  • Based on End-use, market is studied across Academic & Research Institutes and Pharmaceutical.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in adoption of advanced 3D biocompatible materials for medical applications.
      • 5.1.1.2. Growing demand for biocompatible materials for drug delivery systems, cosmetic implants, and wound dressing
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the development of biocompatible materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing focus on personalized medicines and customized medical devices and implants
      • 5.1.3.2. Increasing demand for regenerative medicines for providing scaffolds, carriers for tissue engineering, and cell-based therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and standards for approval of biocompatible materials
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biocompatible Materials Market, by Material Type

  • 6.1. Introduction
  • 6.2. Biocompatible Ceramic
  • 6.3. Biocompatible Metals
  • 6.4. Natural Polymers
  • 6.5. Synthetic Polymers

7. Biocompatible Materials Market, by End-use

  • 7.1. Introduction
  • 7.2. Academic & Research Institutes
  • 7.3. Pharmaceutical

8. Americas Biocompatible Materials Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biocompatible Materials Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biocompatible Materials Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3 H Technology Institute, LLC
  • 2. 3D Systems Corporation
  • 3. Ashland Inc.
  • 4. BASF SE
  • 5. Baxter International, Inc.
  • 6. Celanese Corporation
  • 7. Covestro AG
  • 8. DuPont de Nemours, Inc.
  • 9. Elix Polymers SLU
  • 10. Ensinger GmbH
  • 11. EOS GmbH
  • 12. Evonik Industries AG
  • 13. Formlabs Inc.
  • 14. Foster Corporation.
  • 15. Henkel AG & Co. KGaA,
  • 16. Koninklijke DSM N.V.
  • 17. Kurt J. Lesker Company GmbH
  • 18. Merck KGaA
  • 19. Mitsubishi Chemical Corporation
  • 20. Renishaw PLC
  • 21. Sandvik AB
  • 22. Shin-Etsu Chemical Co., Ltd.
  • 23. Stratasys Ltd.
  • 24. Stryker Corporation
  • 25. Wacker Chemie AG

LIST OF FIGURES

  • FIGURE 1. BIOCOMPATIBLE MATERIALS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOCOMPATIBLE MATERIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOCOMPATIBLE MATERIALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOCOMPATIBLE MATERIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOCOMPATIBLE MATERIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOCOMPATIBLE MATERIALS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY BIOCOMPATIBLE CERAMIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY BIOCOMPATIBLE METALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY NATURAL POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. BIOCOMPATIBLE MATERIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. BIOCOMPATIBLE MATERIALS MARKET, FPNV POSITIONING MATRIX, 2023